secwatch.observer — SEC 8-K summary
======================================

Issuer:     PULSE BIOSCIENCES, INC. (PLSE)
CIK:        0001625101
Form:       8-K
Filed at:   2026-01-14T23:59:59+00:00
Accession:  0001437749-26-001225
Event type: other_material
Sentiment:  neutral
Materiality: 0.30
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pulse Biosciences posts investor deck detailing progress on nPulse devices
--------------------------------------------------------------------------

- Updated investor presentation highlights recent progress on nPulse Vybrance Percutaneous Electrode, Cardiac Clamp, and Cardiac Catheter.
- Presentation posted January 14, 2026; company expects to use it in investor meetings and analyst calls.
- Deck available on company website under Investors section; no financial or clinical data disclosed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1625101/000143774926001225/0001437749-26-001225-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1625101/000143774926001225/plse20260113_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-26-001225

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer